Company Filing History:
1 out of 4 
1 out of 59 
1 out of 15 
Years Active: 2014
Title: **Ayumu Muroya: Innovator in Anticancer Compounds**
Introduction
Ayumu Muroya is a distinguished inventor based in Chuo-ku, Japan. With a focus on developing innovative compounds, Muroya has made significant contributions to the field of pharmaceuticals, particularly in the quest for effective cancer treatments.
Latest Patents
Muroya holds a notable patent for a compound classified as a 1,3,4-Oxadiazole-2-carboxamide. This compound exhibits STAT3 inhibitory activity, making it a promising candidate as an anticancer agent. The patent details a specific formula (I) or its pharmacologically acceptable salts, which includes components such as a furyl group and a diaryl group like a biphenyl. This innovation represents a breakthrough in developing new therapeutic agents to combat cancer.
Career Highlights
Throughout his career, Ayumu Muroya has collaborated with various organizations in the pharmaceutical sector. He has worked with the General Incorporated Association Pharma Valley Project Supporting Organization and Pharmadesign, Inc. His efforts have contributed to significant advancements in pharmaceutical chemistry and drug development.
Collaborations
Muroya has collaborated closely with coworkers such as Akira Asai and Kenji Matsuno, fostering a collaborative environment that facilitates the advancement of innovative research and development in their field. Their collective expertise further enhances the potential impact of Muroya’s discoveries.
Conclusion
Ayumu Muroya exemplifies the spirit of innovation within the pharmaceutical industry. His work on the 1,3,4-Oxadiazole-2-carboxamide compound underscores the importance of research in developing new solutions for cancer treatment. As he continues to contribute to the field, Muroya's inventions hold promise for the future of medicine and oncology.